ACQUASALIENTE, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 2.709
EU - Europa 583
AS - Asia 190
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 3.484
Nazione #
US - Stati Uniti d'America 2.707
IT - Italia 299
CN - Cina 158
DE - Germania 107
FI - Finlandia 46
SE - Svezia 31
IE - Irlanda 24
GB - Regno Unito 21
RU - Federazione Russa 21
KR - Corea 12
FR - Francia 10
NL - Olanda 8
CH - Svizzera 7
IN - India 7
HK - Hong Kong 5
UA - Ucraina 5
PT - Portogallo 3
SG - Singapore 3
CA - Canada 2
AT - Austria 1
AU - Australia 1
BD - Bangladesh 1
EU - Europa 1
JP - Giappone 1
PH - Filippine 1
TH - Thailandia 1
TR - Turchia 1
Totale 3.484
Città #
Fairfield 454
Ashburn 296
Ann Arbor 261
Woodbridge 250
Chandler 207
Houston 187
Seattle 152
Cambridge 145
Wilmington 132
Padova 126
Princeton 55
San Diego 50
Medford 49
Des Moines 46
Beijing 41
Roxbury 36
Boardman 35
Helsinki 23
Milan 21
Nanjing 21
Dublin 19
Guangzhou 19
Washington 13
Jacksonville 12
New York 11
Saint Louis 11
Seoul 11
Shenyang 10
London 8
Vicenza 8
Cagliari 7
Hebei 6
Ogden 6
Boston 5
Florence 5
Nanchang 5
San Donà Di Piave 5
Trieste 5
Zurich 5
Fulham 4
Hefei 4
Hong Kong 4
Norwalk 4
Paris 4
Rome 4
Torino 4
Zhengzhou 4
Agordo 3
Amsterdam 3
Bologna 3
Canelli 3
Changsha 3
Haikou 3
Jiaxing 3
Kharkiv 3
Lappeenranta 3
Ningbo 3
Pune 3
Singapore 3
Taizhou 3
Tolentino 3
Verona 3
Ahmedabad 2
Aveiro 2
Berlin 2
Borås 2
Cherasco 2
Columbus 2
Dearborn 2
Edinburgh 2
Fuzhou 2
Hangzhou 2
Hosur 2
Hounslow 2
Jinan 2
Kunming 2
Mirano 2
Nembro 2
Pescara 2
Redmond 2
Rockville 2
Senago 2
Spoltore 2
Tianjin 2
Toulon 2
Travagliato 2
Treviso 2
Turin 2
Venice 2
Aprilia 1
Bangkok 1
Bari 1
Belluno 1
Busto Arsizio 1
Codroipo 1
Cork 1
Curtarolo 1
Dallas 1
Dhaka 1
Dongguan 1
Totale 2.900
Nome #
Identifying conformational changes with site-directed spin labeling reveals that the GTPase domain of HydF is a molecular switch 158
Endocrine disruption of androgenic activity by perfluoroalkyl substances: clinical and experimental evidence 154
Noncoded amino acids in protein engineering: Structure-activity relationship studies of hirudin-thrombin interaction 150
A MICU1 Splice Variant Confers High Sensitivity to the Mitochondrial Ca2+ Uptake Machinery of Skeletal Muscle 145
Effects of point mutations in the binding pocket of the mouse major urinary protein MUP20 on ligand affinity and specificity 135
Onconase dimerization through 3D domain swapping: Structural investigations and increase in the apoptotic effect in cancer cells* 125
Protein Engineering by Chemical Methods: Incorporation of Nonnatural Amino Acids as a Tool for Studying Protein Folding, Stability, and Function 119
Probing prothrombin structure by limited proteolysis 116
Loop Electrostatics Asymmetry Modulates the Preexisting Conformational Equilibrium in Thrombin 113
Perfluorooctanoic acid alters progesterone activity in human endometrial cells and induces reproductive alterations in young women 113
Coagulation protein factors: discovering novel interactions of thrombin 113
Circulating β2 glycoprotein I-IgG anti-β2 glycoprotein I immunocomplexes in patients with definite Antiphospholipid Syndrome. 112
Interplay between conformational selection and zymogen activation 104
Thrombin Inhibits the Anti-Myeloperoxidase and Ferroxidase Functions of Ceruloplasmin: Relevance in Rheumatoid Arthritis 96
Lupus anticoagulant identifies two distinct groups of patients with different antibody patterns 94
Polyphenols as Potential Therapeutic Drugs in Neurodegeneration 89
Endocrine Disruption of Vitamin D Activity by Perfluoro-Octanoic Acid (PFOA) 85
Identifying novel thrombin interactions: alpha-synuclein binds to thrombin exosites and inhibits thrombin-mediated platelet aggregation 82
β2-Glycoprotein I Binds to Thrombin and Selectively Inhibits the Enzyme Procoagulant Functions 82
Molecular Mapping of α -Thrombin( α T)/ β 2-Glycoprotein I(β2GpI) Interaction Reveals How β2GpI Affects α T Functions 78
Sperm cholesterol content modifies sperm function and trpv1‐mediated sperm migration 77
Thrombin binds to human ceruloplasmin and proteolytically hinders its antioxidant activity 65
Synthesis and characterization of HAEMANORM-I: A novel highly potent bivalent thrombin inhibitor based on the structure of haemadin 64
NOG-Derived Peptides Can Restore Neuritogenesis on a CRASH Syndrome Cell Model 63
Thrombin allostery: effect of exosite-1 and exosite-2 binders on the enzyme molecular recognition and catalysis 61
Beta 2 glycoprotein I selectively inhibits the procoagulant function of thrombin: a novel physiologic anticoagulant mechanism in haemostasis 60
Beta2-glycoprotein I selectively inhibits the procoagulant functions of thrombin 59
Novel Interactions of Thrombin 55
A conserved Neurite Outgrowth and Guidance motif with biomimetic potential in neuronal Cell Adhesion Molecules 55
Von Willebrand factor multimers and the relaxation response: A one-year study 53
Understanding thrombin allostery: Effect of exosite-1 and exosite-2 binders on enzyme recognition and catalysis 52
Non-canonical proteolytic activation of human prothrombin by subtilisin from Bacillus subtilis may shift the procoagulantâ anticoagulant equilibrium toward thrombosis 51
Identifying novel thrombin interactions: Alpha-synuclein binds to thrombin exosites and inhibits thrombin-mediated platelet aggregation 45
Mapping specificity, cleavage entropy, allosteric changes and substrates of blood proteases in a high-throughput screen 44
Structural Features and Toxicity of α-Synuclein Oligomers Grown in the Presence of DOPAC 42
Alternative proteolytic activation of human prothrombin by a bacterial serine protease 41
Thrombin binds human ceruloplasmin and proteolytically hinders its antioxidant activity: implications in the pathogenesis of rheumatoid arthritis 40
The role of bacterial proteases in prothrombin activation. 39
Thrombin binds human ceruloplasmin and proteolytically hinders its antioxidant activity: implication in the pathogenesis of rheumatoid arthritis 38
Novel thrombin interactions: alpha-synuclein binds thrombin exosites and inhibits thrombin-mediated platelet aggregation 31
Thrombin binds to human ceruloplasmin and proteolytically hinders its antioxidant activity 30
Exogenous human α-Synuclein acts in vitro as a mild platelet antiaggregant inhibiting α-thrombin-induced platelet activation 23
Identification of methionine sulfoxide at position 1606 of von Willebrand Factor (vWF) as a risk factor for thrombosis in patients with Antiphospholipid Syndrome (APS). 23
Preliminary Discovery of Small Molecule Inhibitors of Epidermal Growth Factor Receptor (EGFR) That Bind to the Extracellular Domain 20
Importance of Prothrombin domains on the mechanism of activation. 20
Human alpha-thrombin binds to and potently inhibits leukocyte myeloperoxidase: A novel Biochemical link between inflammation and coagulation 19
Characterization of a catalytically active thrombin precursor generated by non-canonical proteolytic activation 18
The role of high molecular weight hyaluronic acid in mucoadhesion on an ocular surface model 17
Aerosolized sulfated hyaluronan derivatives prolong the survival of K18 ACE2 mice infected with a lethal dose of SARS-CoV-2 15
β2GpI binds to fibrinogen and alters fibrin generation and degradation 12
Thrombin proteolytically hinders the antioxidant activity of human ceruloplasmin: Implications in the pathogenesis of rheumatoid arthritis. 12
Bacterial biofilms from Staphylococcus sp. trigger activation of coagulation: a possible link between infections and cardiovascular diseases 9
Bacterial biofilms produced by Staphylococcus sp. act as molecular scaffolds for the activation of blood coagulation 9
Mapping of thrombin - Beta2-glycoprotein I interaction sites. 9
Staphylococcal biofilms: molecular scaffolds for the activation of blood coagulation 7
The Role of Proteolysis in Amyloidosis 5
From Haemadin to Haemanorm: Synthesis and Characterization of Full-length Haemadin from the leech Haemadipsa sylvestris and of a Novel Bivalent, Highly Potent Thrombin Inhibitor (Haemanorm) 5
A novel genetically-encoded bicyclic peptide inhibitor of human urokinase-type plasminogen activator with better cross-reactivity toward the murine orthologue 4
Bacterial biofilms from Staphylococcus sp. trigger activation of coagulation: a possible link between infections and cardiovascular diseases 3
Totale 3.558
Categoria #
all - tutte 12.069
article - articoli 8.735
book - libri 246
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.050


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019163 0 0 0 0 0 0 0 0 0 37 63 63
2019/2020659 58 28 28 126 65 33 74 63 66 74 32 12
2020/2021622 51 62 42 70 4 10 29 45 49 95 50 115
2021/2022602 11 101 34 48 28 30 53 56 30 13 46 152
2022/2023533 100 51 17 47 85 62 12 33 62 18 28 18
2023/2024491 18 58 58 42 50 75 34 96 26 34 0 0
Totale 3.558